This is now a feature of the United Health Group’s strategy in response to the death of former CEO Brian Thomson.
Investors prosecuting the United Health Group claims that the company’s high -level administration has stopped information about how to affect the profit and operations of its former chief executive Brian Thomson.
According to CBS News, the proposed class action case was filed in the US district court on Wednesday for the southern district of New York. In judicial documents, investor Roberto Feller has alleged that when the income per share per share increases from $ 29.50 to 30 in December, United Health “artificially increased prices”.
Later, in January, the United Health Group repeated its predictions despite a severe scrutiny of Thomson’s death and its methods.
Brian Thomson, who served as the CEO of the United Health Group since April 2021, was killed by a masked man in New York City in December 2024. The Brazin murder made national headlines, but they failed to create more sympathy for Thomson or his company. Instead, many people took the opportunity to criticize the United Health Group for a high rate of claims, some suggested that Thomson’s actions as CEO termed him more responsible for the suspected shooter Logi Mangoin.
The criticism of the United Health Group was partially run by the Senate results of October 2024, which states that it has a higher rate of refusal to claim.
Feller’s legalization now presents the United Health Group’s strategy as a “aggressive, consumer strategy” in response to Thomson’s death. After Thomson’s death, these plans became “rapidly controversial”. Nevertheless, the United Health Group was hoping to provide the expected profit of the share range from $ 29.50 to 30.
The United Health Group eventually reduced its predictions to $ 26 and $ 26.50.
Feller’s lawyers say, before the revision, the United Health Group created a series of “materially false and misleading” statements, all of which allegedly failed to properly inform the shareholders that the company would have to adjust its strategy to the industry.
The litigation alleges that “as a result of the defendants’ wrongdoing and mistakes, and the rapid decline in the company’s security market value, the plaintiff and other class members have suffered significant losses and losses.”
The legal proceedings have also been asked by the federal judge to oversee the case so that it can be confirmed by the class action case. If the approval is received, the class will likely consist of each one that bought, sold, sold, sold, and sold shares of the United Health Group between December 3, 2024 and April 16, 2025.
The defendants of the litigation, including the United Health Group’s chief executive Andrew Witty and the Chief Financial Officer John Rex.
Sources
CEO’s response after the killing of United Health by investors
United Healthcare prosecuting the CEO’s murder by shareholders
